Ananda Developments - Ananda Presentation to LSX Conference 2024
Reach
Latest announcements
Announcement summary
Ananda Developments - Ananda Presentation to LSX Conference 2024
Jeremy Sturgess-Smith, Ananda Finance Director, delivered a comprehensive presentation to potential investors and other industry leaders, showcasing the Company’s progress in developing patent pending CBD formulations as regulated drugs for chemotherapy induced peripheral pain and endometriosis at the LSX World Congress on 29 April 2024.
Ask a question
Your question will be sent privately to Ananda Pharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Ananda Pharma a question about this announcement.